Gastric inhibitory polypeptide diagnostic test for detecting susceptibility to type-2 diabetes, impaired glucose tolerance, or impaired fasting glucose
ZA200102694B
Enzymatic amidation of peptides.
AU3494701A
Antimicrobial peptides isolated from the skin of the hyperoliid frog, kassina senegalensis
ZA200007383B
Glucagon-like peptide-1 improves β-cell response to glucose in subjects with impaired glucose tolerance.
EP1104437A2
Antimicrobial peptides isolated from the skin of american frogs
US6344180B1
GLP-1 as a diagnostic test to determine β-cell function and the presence of the condition of IGT and type II diabetes
US6429197B1
Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain
US6284725B1
Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue
AU3087599A
Human appetite control by glucagon-like peptide receptor binding compounds
US6461834B1
Clostripain catalyzed amidation of peptides
US5972656A
Mercury binding polypeptides and nucleotides coding therefore
US5846774A
Chlorella virus promoters
CA2245681A1
Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs
US6111079A
Lead binding polypeptides and nucleotides coding therefore
AU6900696A
Method and composition for enhanced parenteral nutrition
AU6094696A
Lead binding polypeptides and nucleotides coding therefor
